NCT01517802 A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate Status COMPLETED Phase PHASE3
NCT01503229 Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Status COMPLETED Phase PHASE2
NCT01485861 Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy Status COMPLETED Phase PHASE1/PHASE2
NCT01478308 Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer Status WITHDRAWN Phase PHASE2
NCT01469338 Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel Status TERMINATED Phase PHASE2
NCT01468532 Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01452100 Efficacy of Prednisone in Patients With Severe Systemic Atheroembolism (Cholesterol Cristal Embolism) Status TERMINATED Phase PHASE2
NCT01451515 NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma Status COMPLETED Phase PHASE2
NCT01445535 Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas Status COMPLETED Phase PHASE1
NCT01432080 Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant Status TERMINATED Phase PHASE2
NCT01424982 Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01424930 A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancer Status COMPLETED Phase PHASE2
NCT01415765 MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma Status WITHDRAWN Phase PHASE1/PHASE2
NCT01414855 A Study of Obinutuzumab [RO5072759 (GA101)] in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma (GATHER) Status COMPLETED Phase PHASE2
NCT01411514 Oral Prednisone Taper Versus Placebo for the Treatment of Acute Relapses in Multiple Sclerosis Status TERMINATED Phase PHASE4
NCT01407484 Male Infertility Related With Post Infection Inflammatory Syndrome Status COMPLETED Phase NA
NCT01393730 Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer Status COMPLETED Phase PHASE2
NCT01393639 Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis Status COMPLETED Phase PHASE2